Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION, INFUSION BAGS".
Press Release Oct 23 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Caplin Point Laboratories Limited on 6ix
Earlier from Caplin Point Laboratories
- Press Release Sep 03 2025
- Press Release May 14 2025
- Press Release Apr 23 2025
- Press Release Feb 26 2025
- Press Release Feb 05 2025
Later from Caplin Point Laboratories
- Press Release Jan 27 2026
- Press Release Feb 24 2026
- Press Release Feb 28 2026
- Press Release Mar 13 2026
- Press Release May 05 2026
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories